An estrogen replacement therapy containing nine synthetic plant-based conjugated estrogens promotes neuronal survival

Experimental Biology and Medicine

Volumn 228, Issue 7, 2003, Pages 823-835

  Zhao, Lixia ^a   Chen, Shuhua ^a   Brinton, Roberta D ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Estrogen; Estrogen replacement therapy; Hippocampus; Neuroprotection; SCE; Synthetic conjugated estrogens

Indexed keywords

17ALPHA DIHYDROEQUILENIN; 17ALPHA ESTRADIOL; 17BETA DIHYDROEQUILENIN; 17BETA DIHYDROEQUILIN; AMYLOID BETA PROTEIN; CALCIUM ION; CONJUGATED ESTROGEN; DIHYDROEQUILIN; EQUILENIN; ESTRADIOL; ESTRONE SULFATE; GLUTAMIC ACID; HYDROGEN PEROXIDE; LACTATE DEHYDROGENASE; NEUROTOXIN; PLANT EXTRACT; SODIUM EQUILIN; UNCLASSIFIED DRUG; YAM EXTRACT; CALCIUM; NEUROPROTECTIVE AGENT;

ALZHEIMER DISEASE; ANIMAL CELL; APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; ENZYME RELEASE; ESTROGEN ACTIVITY; ESTROGEN THERAPY; FETUS; HIGH RISK POPULATION; HIPPOCAMPUS; IN VIVO STUDY; NERVE CELL; NERVE CELL CULTURE; NERVE CELL NECROSIS; NEUROPHARMACOLOGY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; POSTMENOPAUSE; QUANTITATIVE ANALYSIS; RAT; RECURRENCE RISK; SOYBEAN; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CHEMISTRY; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; METABOLISM; METHODOLOGY; SPRAGUE DAWLEY RAT; ULTRASTRUCTURE; YAM;

ANIMALIA; DIOSCOREA ALATA; EQUIDAE; GLYCINE MAX;

AMYLOID BETA-PROTEIN; ANIMALS; APOPTOSIS; CALCIUM; CELL SURVIVAL; CELLS, CULTURED; DIOSCOREA; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, CONJUGATED (USP); GLUTAMIC ACID; HIPPOCAMPUS; HYDROGEN PEROXIDE; L-LACTATE DEHYDROGENASE; NEURONS; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; SOYBEANS;

EID: 0141791272     PISSN: 15353702     EISSN: None     Source Type: Journal    
DOI: 10.1177/15353702-0322807-08     Document Type: Article

References (64)

1. Brinton RD. Estrogens and Alzheimer's Disease. In: Marwah J, Teitelbaum H, Eds. Advances in Neurodegenerative Disorders. Alzheimer's and Aging. Scottsdale, AZ: Prominent Press, Vol 1:p 99-130, 1998.
2. Sherwin BB. Oestrogen and cognitive function throughout the female lifespan. Novartis Found Symp 230:188-19, 2000.
3. Birge SJ. Is there a role for estrogen replacement therapy in the prevention and treatment of dementia? J Am Geriatr Soc 44:865-870, 1996.
4. Henderson VW. Hormone therapy and the brain: A clinical perspective on the role of estrogen. New York/London: Parthenon Publishing; 2000.
5. Paganini-Hill A, Henderson VW. Estrogen replacement therapy and risk of Alzheimer disease. Arch Intern Med 156:2213-2217, 1996.
6. Tang MX, Jacobs D, Stem Y, Marder K, Schofield P, Gurland B, Andrews H, Mayeux R. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 348:429-432, 1996.
7. Kawas C, Resnick S, Morrison A, Brookmeyer R, Corrada M, Zonderman A, Bacal C, Lingle DD, Metter E. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: The Baltimore Longitudinal Study of Aging. Neurology 48:1517-1521, 1997.
8. Yaffe K, Sawaya G, Lieberburg I, Grady D. Estrogen therapy in postmenopausal women: Effects on cognitive function and dementia. JAMA 279:688-695, 1998.
9. Henderson VW. Estrogen, cognition, and a woman's risk of Alzheimer's disease. Am J Med 103:11S-18S, 1997.
10. Green PS, Gridley KE, Simpkins JW. Estradiol protects against beta-amyloid (25-35)-induced toxicity in SK-N-SH human neuroblastoma cells. Neurosci Lett 218:165-168, 1996.
11. Behl C, Skutella T, Lezoualc'h F, Post A, Widmann M, Newton CJ, Holsboer F. Neuroprotection against oxidative stress by estrogens: Structure-activity relationship. Mol Pharmacol 51:535-541, 1997.
12. Brinton RD, Chen S, Montoya M, Hsieh D, Minaya J, Kim J, Chu H. The women's health initiative estrogen replacement therapy is neurotrophic and neuroprotective. Neurobiol Aging 21:457-496, 2000.
13. Brinton RD. Cellular and molecular mechanisms of estrogen regulation of memory function and neuroprotection against Alzheimer's disease: recent insights and remaining challenges. Learn Mem 8:121-133, 2001.
14. Maki P, Zonderman A, Resnick S. Enhanced verbal memory in nondemented elderly women receiving hormone-replacement therapy. Am J Psychiatry 158:227-233, 2001.
15. Wolf OT, Kirschbaum C. Endogenous estradiol and testosterone levels are associated with cognitive performance in older women and men. Horm Behav 41:259-266, 2002.
16. Smith YR, Giordani B, Lajiness-O'Neill R, Zubieta JK. Long-term estrogen replacement is associated with improved nonverbal memory and attentional measures in postmenopausal women. Fertil Steril 76:1101-1107, 2001.
17. Binder EF, Schechtman KB, Birge SJ, Williams DB, Kohrt WM. Effects of hormone replacement therapy on cognitive performance in elderly women. Maturitas 38:137-146, 2001.
18. Singh M, Meyer EM, Millard WJ, Simpkins JW. Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats. Brain Res 644:305-312, 1994.
19. Brinton RD, Proffitt P, Tran J, Luu R. Equilin, a principal component of the estrogen replacement therapy premarin, increases the growth of cortical neurons via an NMDA receptor-dependent mechanism. Exp Neurol 147:211-220, 1997.
20. Drake EB, Henderson VW, Stanczyk FZ, McCleary CA, Brown WS, Smith CA, Rizzo AA, Murdock GA, Buckwalter JG. Associations between circulating sex steroid hormones and cognition in normal elderly women. Neurology 54:599-603, 2000.
21. Simpkins JW, Green PS, Gridley KE, Singh M, de Fiebre NC, Rajakumar G. Role of estrogen replacement therapy in memory enhancement and the prevention of neuronal loss associated with Alzheimer's disease. Am J Med 103:19S-25S, 1997.
22. Toran-Allerand CD. On the genesis of sexual differentiation of the general nervous system: morphogenetic consequences of steroidal exposure and possible role of alpha-fetoprotein. Prog Brain Res 61:63-98, 1984.
23. Brinton RD. 17 beta-estradiol induction of filopodial growth in cultured hippocampal neurons within minutes of exposure. Mol Cell Neurosci 4:36-46. 1993.
24. Murphy DD, Segal M. Regulation of dendritic spine density in cultured rat hippocampal neurons by steroid hormones. J Neurosci 16:4059-4068, 1996.
25. Brinton RD, Tran J, Proffitt P, Montoya M. 17 beta-Estradiol enhances the outgrowth and survival of neocortical neurons in culture. Neurochem Res 22:1339-1351, 1997.
26. Woolley CS. Electrophysiological and cellular effects of estrogen on neuronal function. Crit Rev Neurobiol 13:1-20, 1999.
27. Sandstrom NJ, Williams CL. Memory retention is modulated by acute estradiol and progesterone replacement. Behav Neurosci 115:384-393, 2001.
28. Stevens RE, Hanford K, Wason S, Cusack SL, Phelps KV. A 12-week clinical trial determining the efficacy of synthetic conjugated estrogens, A (SCE), in the treatment of vasomotor symptoms in menopausal women. Int J Fertil Womens Med 45:264-272, 2000.
29. Mattson MP, Kater SB. Excitatory and inhibitory neurotransmitters in the generation and degeneration of hippocampal neuroarchitecture. Brain Res 478:337-348, 1989.
30. Behl C. Vitamin E and other antioxidants in neuroprotection. Int J Vitam Nutr Res 69:213-219, 1999.
31. Boveris A, Cadenas E. Cellular sources and steady-state levels of reactive oxygen species. In: Clerch LB, Massaro DJ, Eds. Oxygen, Gene Expression, and Cellular Function. New York: Marcel Dekker, pp1-25, 1997.
32. Liu J, Shigenaga MK, Mori A, Ames BN. Free radicals and neurodegenerative disease: stress and oxidative stress. In: Packer L, Hiramatsu M, Yoshikawa T, Eds. Free radicals in brain physiology and disorders. San Diego, CA: Academic Press, pp403-437, 1996.
33. Behl C. Alzheimer's disease and oxidative stress: Implications for novel therapeutic approaches. Prog Neurobiol 57:301-323, 1999.
34. Brinton R, Yamazaki R. Therapeutic advances and challenges in the treatment of Alzheimer's Disease. Pharm Res 15:384-397, 1998.
35. Choi DW. Glutamate neurotoxicity in cortical cell culture is calcium dependent. Neurosci Lett 58:293-297, 1985.
36. Perez Velazquez JL, Frantseva MV, Carlen PL. In vitro ischemia promotes glutamate-mediated free radical generation and intracellular calcium accumulation in hippocampal pyramidal neurons. J Neurosci 17:9085-9094, 1997.
37. Mattson MP. Calcium as sculptor and destroyer of neural circuitry. Exp Gerontol 27:29-49, 1992.
38. Coyle JT, Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 262:689-695, 1993.
39. 2+ homeostasis in Alzheimer's disease. Trends Neurosci 16:409-414, 1993.
40. Behl C. Amyloid beta-protein toxicity and oxidative stress in Alzheimer's disease. Cell Tissue Res 290:471-480, 1997.
41. Behl C, Davis JB, Lesley R, Schubert D. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 77:817-827, 1994.
42. 2+ homeostasis. Neurosci Res 37:227-236, 2000.
43. Kaminska B, Figiel I, Pyrzynska B, Czajkowski R, Mosieniak G. Treatment of hippocampal neurons with cyclosporin A results in calcium overload and apoptosis which are independent on NMDA receptor activation. Br J Pharmacol 133:997-1004, 2001.
44. Furukawa K, Fu W, Li Y, Witke W, Kwiatkowski DJ, Mattson MP. The actin-severing protein gelsolin modulates calcium channel and NMDA receptor activities and vulnerability to excitotoxicity in hippocampal neurons. J Neurosci 17:8178-8186, 1997.
45. Mattson MP, Lovell MA, Furukawa K, Markesbery WR. Neurotrophic factors attenuate glutamate-induced accumulation of peroxides, elevation of intracellular Ca2+ concentration, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons. J Neurochem 65:1740-1751, 1995.
46. Mattson MP, Murrain M, Guthrie PB, Kater SB. Fibroblast growth factor and glutamate: opposing roles in the generation and degeneration of hippocampal neuroarchitecture. J Neurosci 9:3728-3740, 1989.
47. Nilsen J, Brinton RD. Impact of progestins on estradiol regulation of neural calcium responses: Synergy by progesterone and antagonism by medroxyprogesterone acetate. Soc Neurosci Abs 27:2001.
48. Nilsen J, Brinton RD. Impact of progestins on estrogen-induced neuroprotection: synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate. Endocrinology 143:205-212, 2002.
49. Dubal DB, Zhu H, Yu J, Rau SW, Shughrue PJ, Merchenthaler I, Kindy MS, Wise PM. Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury. Proc Natl Acad Sci USA 98:1952-1957, 2001.
50. Kim H, Bang OY, Jung MW, Ha SD, Hong HS, Huh K, Kim SU, Mook-Jung I. Neuroprotective effects of estrogen against beta-amyloid toxicity are mediated by estrogen receptors in cultured neuronal cells. Neurosci Lett 302:58-62, 2001.
51. Wang L, Andersson S, Warner M, Gustafsson JA. Morphological abnormalities in the brains of estrogen receptor beta knockout mice. Proc Natl Acad Sci USA 98:2792-2796, 2001.
52. Rissman EF, Heck AL, Leonard JE, Shupnik MA, Gustafsson JA. Disruption of estrogen receptor beta gene impairs spatial learning in female mice. Proc Natl Acad Sci USA 99:3996-4001, 2002.
53. Behl C. Oestrogen as a neuroprotective hormone. Nat Rev Neurosci 3:433-442, 2002.
54. Sugioka K, Shimosegawa Y, Nakano M. Estrogens as natural antioxidants of membrane phospholipid peroxidation. FEBS Lett 210:37-39, 1987.
55. Moosmann B, Behl C. The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties. Proc Natl Acad Sci USA 96:8867-8872, 1999.
56. Green PS, Gordon K, Simpkins JW. Phenolic A ring requirement for the neuroprotective effects of steroids. J Steroid Biochem Mol Biol 63:229-235, 1997.
57. Bi R, Broutman G, Foy MR, Thompson RF, Baudry M. The tyrosine kinase and mitogen-activated protein kinase pathways mediate multiple effects of estrogen in hippocampus. Proc Natl Acad Sci USA 97:3602-3607, 2000.
58. Nilsen J, Chen S, Brinton RD. Dual action of estrogen on glutamate-induced calcium signaling: mechanisms requiring interaction between estrogen receptors and src/mitogen activated protein kinase pathway. Brain Res 930:216-234, 2002.
59. Singh M, Setalo G Jr, Guan X, Warren M, Toran-Allerand CD. Estrogen-induced activation of mitogen-activated protein kinase in cerebral cortical explants: Convergence of estrogen and neurotrophin signaling pathways. J Neurosci 19:1179-1188, 1999.
60. Singer CA, Figueroa-Masot XA, Batchelor RH, Dorsa DM. The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J Neurosci 19:2455-2463, 1999.
61. Pugazhenthi S, Nesterova A, Sable C, Heidenreich KA, Boxer LM, Heasley LE, Reusch JE. Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein. J Biol Chem 275:10761-10766, 2000.
62. Singh M. Ovarian hormones elicit phosphorylation of Akt and extracellular-signal regulated kinase in explants of the cerebral cortex. Endocrine 14:407-415, 2001.
63. Murphy AN, Bredesen DE, Cortopassi G, Wang E, Fiskum G. Bcl-2 potentiates the maximal calcium uptake capacity of neural cell mitochondria. Proc Natl Acad Sci USA 93:9893-9898, 1996.
64. Zhu L, Ling S, Yu XD, Venkatesh LK, Subramanian T, Chinnadurai G, Kuo TH. Modulation of mitochondrial Ca(2+) homeostasis by Bcl-2. J Biol Chem 274:33267-33273, 1999.